Monitoring Strategy Baseline (before starting): Complete pain assessment with validated tools Neurological examination Basic metabolic panel, HbA1c (if diabetic), vitamin B12, TSH INR if on warfarin Cardiovascular risk assessment Ongoing: Pain assessment every 4-8 weeks initially, then every 12 weeks INR weekly 2 weeks then monthly if on warfarin Neurological examination every 6-12 months Annual laboratory monitoring for long-term use 4
doi: 10.1093/carcin/18.2.451
Roscea moderada o severa requiere evaluacin dermatolgica
DHA treatment significantly reduces miR-21 expression in MCF-7 breast cancer cells while enhancing exosomal packaging of miR-23b, miR-27b, miR-320b, and let-7a (63)
Ostrzykujemy si wic coraz chtniej i odwaniej
Other ingredients Calcium carbonate, microcrystalline cellulose (plant fiber), stearic acid, magnesium stearate, aqueous film coating (purified water, hydroxypropyl methylcellulose, vegetable glycerin), silica